147 related articles for article (PubMed ID: 30719160)
1. The impact of SPARC expression on the survival of pancreatic ductal adenocarcinoma patients after curative resection.
Murakawa M; Aoyama T; Miyagi Y; Kobayashi S; Ueno M; Morimoto M; Numata M; Yamamoto N; Tamagawa H; Yukawa N; Rino Y; Masuda M; Morinaga S
J Cancer; 2019; 10(3):627-633. PubMed ID: 30719160
[No Abstract] [Full Text] [Related]
2. Peritumoral fibroblast SPARC expression and patient outcome with resectable pancreatic adenocarcinoma.
Infante JR; Matsubayashi H; Sato N; Tonascia J; Klein AP; Riall TA; Yeo C; Iacobuzio-Donahue C; Goggins M
J Clin Oncol; 2007 Jan; 25(3):319-25. PubMed ID: 17235047
[TBL] [Abstract][Full Text] [Related]
3. The role of SPARC expression in pancreatic cancer progression and patient survival.
Gundewar C; Sasor A; Hilmersson KS; Andersson R; Ansari D
Scand J Gastroenterol; 2015; 50(9):1170-4. PubMed ID: 25765175
[TBL] [Abstract][Full Text] [Related]
4. Peritumoral SPARC expression and patient outcome with resectable intrahepatic cholangiocarcinoma.
Cheng CT; Chu YY; Yeh CN; Huang SC; Chen MH; Wang SY; Tsai CY; Chiang KC; Chen YY; Ma MC; Liu CT; Chen TW; Yeh TS
Onco Targets Ther; 2015; 8():1899-907. PubMed ID: 26251613
[TBL] [Abstract][Full Text] [Related]
5. SPARC mRNA expression as a prognostic marker for pancreatic adenocarcinoma patients.
Miyoshi K; Sato N; Ohuchida K; Mizumoto K; Tanaka M
Anticancer Res; 2010 Mar; 30(3):867-71. PubMed ID: 20393008
[TBL] [Abstract][Full Text] [Related]
6. The relationship between SPARC expression in primary tumor and metastatic lymph node of resected pancreatic cancer patients and patients' survival.
Yu XZ; Guo ZY; Di Y; Yang F; Ouyang Q; Fu DL; Jin C
Hepatobiliary Pancreat Dis Int; 2017 Feb; 16(1):104-109. PubMed ID: 28119265
[TBL] [Abstract][Full Text] [Related]
7. Impact of SPARC expression on outcome in patients with advanced pancreatic cancer not receiving nab-paclitaxel: a pooled analysis from prospective clinical and translational trials.
Ormanns S; Haas M; Baechmann S; Altendorf-Hofmann A; Remold A; Quietzsch D; Clemens MR; Bentz M; Geissler M; Lambertz H; Kruger S; Kirchner T; Heinemann V; Boeck S
Br J Cancer; 2016 Dec; 115(12):1520-1529. PubMed ID: 27802454
[TBL] [Abstract][Full Text] [Related]
8. Increased SPARC expression is associated with neoadjuvant therapy in resectable pancreatic ductal adenocarcinoma.
Hartley C; Rowan D; Chen X; Gomez-Arellano L; West AM; Oshima K; Mackinnon AC
Pract Lab Med; 2020 Aug; 21():e00171. PubMed ID: 32548230
[TBL] [Abstract][Full Text] [Related]
9. High secreted protein acidic and rich in cysteine expression in peritumoral fibroblasts predicts better prognosis in patients with resectable gastric cancer.
Nakajima M; Yoshino S; Kanekiyo S; Maeda N; Sakamoto K; Tsunedomi R; Suzuki N; Takeda S; Yamamoto S; Hazama S; Hoshii Y; Oga A; Itoh H; Ueno T; Nagano H
Oncol Lett; 2018 Jan; 15(1):803-812. PubMed ID: 29403557
[TBL] [Abstract][Full Text] [Related]
10. Preoperative independent prognostic factors in patients with borderline resectable pancreatic ductal adenocarcinoma following curative resection: the neutrophil-lymphocyte and platelet-lymphocyte ratios.
Asari S; Matsumoto I; Toyama H; Shinzeki M; Goto T; Ishida J; Ajiki T; Fukumoto T; Ku Y
Surg Today; 2016 May; 46(5):583-92. PubMed ID: 26108488
[TBL] [Abstract][Full Text] [Related]
11. Expression of secreted protein acidic and rich in cysteine is an independent prognostic indicator of a poor clinical outcome in oropharyngeal carcinoma patients.
Yoshida S; Wakisaka N; Kondo S; Moriyama-Kita M; Hirai N; Endo K; Tsuji A; Nakanishi Y; Murono S; Yoshizaki T
Acta Otolaryngol; 2016; 136(2):189-94. PubMed ID: 26523779
[TBL] [Abstract][Full Text] [Related]
12. Analysis of SPARC and TUBB3 as predictors for prognosis in esophageal squamous cell carcinoma receiving nab-paclitaxel plus cisplatin neoadjuvant chemotherapy: a prospective study.
Gong L; Mao W; Chen Q; Jiang Y; Fan Y
Cancer Chemother Pharmacol; 2019 Apr; 83(4):639-647. PubMed ID: 30643929
[TBL] [Abstract][Full Text] [Related]
13. Prognostic impact of tumoral and/or peri-tumoral stromal SPARC expressions after surgery in patients with biliary tract cancer.
Nakashima S; Kobayashi S; Sakai D; Tomokuni A; Tomimaru Y; Hama N; Wada H; Kawamoto K; Marubashi S; Eguchi H; Matsuura N; Doki Y; Mori M; Nagano H
J Surg Oncol; 2014 Dec; 110(8):1016-22. PubMed ID: 25155283
[TBL] [Abstract][Full Text] [Related]
14. The clinical significance of secreted protein acidic and rich in cysteine expression in breast cancer tissue and its association with prognosis.
Guo W; Zhang M; Chen Y; Guo S
J Cancer Res Ther; 2017; 13(5):833-836. PubMed ID: 29237913
[TBL] [Abstract][Full Text] [Related]
15. Prognostic role of secreted protein acidic and rich in cysteine in patients with solid tumors.
Ma Y; Chen H; Ma H; Yao Z; Hu J; Ma J; Zhang X; Chen G; Liu Y
Saudi Med J; 2019 Aug; 40(8):755-765. PubMed ID: 31423511
[TBL] [Abstract][Full Text] [Related]
16. Stromal SPARC expression and patient survival after chemoradiation for non-resectable pancreatic adenocarcinoma.
Mantoni TS; Schendel RR; Rödel F; Niedobitek G; Al-Assar O; Masamune A; Brunner TB
Cancer Biol Ther; 2008 Nov; 7(11):1806-15. PubMed ID: 18787407
[TBL] [Abstract][Full Text] [Related]
17. Secreted protein acidic and rich in cysteine expression in human colorectal cancer predicts postoperative prognosis.
Liu QZ; Gao XH; Chang WJ; Wang HT; Wang H; Cao GW; Fu CG
Eur Rev Med Pharmacol Sci; 2015 May; 19(10):1803-11. PubMed ID: 26044224
[TBL] [Abstract][Full Text] [Related]
18. Preoperative serum C-reactive protein levels and post-operative lymph node ratio are important predictors of survival after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma.
Sanjay P; de Figueiredo RS; Leaver H; Ogston S; Kulli C; Polignano FM; Tait IS
JOP; 2012 Mar; 13(2):199-204. PubMed ID: 22406601
[TBL] [Abstract][Full Text] [Related]
19. SPARC gene variants predict clinical outcome in locally advanced and metastatic pancreatic cancer patients.
Arqueros C; Salazar J; Arranz MJ; Sebio A; Mora J; Sullivan I; Tobeña M; Martín-Richard M; Barnadas A; Baiget M; Páez D
Med Oncol; 2017 Aug; 34(8):136. PubMed ID: 28687963
[TBL] [Abstract][Full Text] [Related]
20. Preoperative CEA and CA 19-9 are prognostic markers for survival after curative resection for ductal adenocarcinoma of the pancreas - a retrospective tumor marker prognostic study.
Distler M; Pilarsky E; Kersting S; Grützmann R
Int J Surg; 2013; 11(10):1067-72. PubMed ID: 24161419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
